Optimizing CareSource Asthma Prior Authorization Workflows
Managing CareSource asthma prior authorization can be a high-volume, resource-intensive task for revenue cycle and prior authorization teams. Klivira provides a robust solution to automate and accelerate this critical process.
For clinics, hospitals, and health systems serving CareSource members, asthma represents a significant disease state driving prior authorization volume for both medications and diagnostic procedures. Optimizing these workflows is essential for patient access to care and maintaining financial viability, especially given CareSource's focus on Medicaid and ACA populations.
Prior Authorization Volume Profile for Asthma Under CareSource
Asthma is a prevalent chronic condition, particularly within the Medicaid and ACA populations that CareSource primarily serves. This demographic often presents with higher rates of uncontrolled asthma and comorbidities, leading to a substantial volume of prior authorization requests for step therapy adherence, specialty medications, and advanced diagnostics. Efficiently processing these PAs is critical to ensure continuity of care and prevent administrative backlogs.
Common Asthma Medications and Procedures Requiring CareSource PA
- Biologic therapies (e.g., omalizumab, mepolizumab, benralizumab, dupilumab)
- High-dose inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) combination products beyond initial prescribing guidelines
- Nebulized solutions, particularly certain long-acting bronchodilators or corticosteroids
- Pulmonary function tests (PFTs) for initial diagnosis or ongoing management beyond routine intervals
- Advanced imaging (e.g., CT scans) for differential diagnosis or comorbidity assessment
CareSource Asthma Disease Management Programs
As a non-profit carrier focused on improving health outcomes, CareSource typically offers comprehensive disease management programs. These initiatives often include care coordination, patient education on medication adherence and trigger avoidance, and support for self-management plans. Understanding and leveraging these programs can inform PA strategies and improve overall patient care pathways for asthma patients.
Relevant HEDIS Measures for Asthma Under CareSource
CareSource, like other managed care organizations, emphasizes performance on HEDIS measures. For asthma, key measures include the Asthma Medication Ratio (AMR), which assesses appropriate medication use, and Use of Appropriate Medications for People with Asthma (ASM). Streamlining prior authorization for guideline-recommended asthma treatments directly supports compliance with these quality metrics, impacting reimbursement and quality ratings.
Automating CareSource Asthma Prior Authorization with Klivira
Klivira's platform automates the submission and tracking of prior authorizations, including those for high-volume conditions like asthma under CareSource. By integrating directly with your EMR and leveraging X12 278, ePA, and payer portal automation, Klivira reduces manual effort, accelerates approval times, and minimizes denials. This ensures CareSource members receive timely access to necessary asthma treatments while optimizing your revenue cycle efficiency.
Frequently asked questions
How does CareSource typically manage prior authorization for asthma medications?
CareSource often employs step therapy protocols and may require prior authorization for specialty biologics, high-dose combination inhalers, or nebulized solutions beyond standard initial prescribing. The process typically involves clinical documentation demonstrating medical necessity and adherence to their specific formulary guidelines for asthma management.
What HEDIS measures are critical for asthma care under CareSource?
Key HEDIS measures for asthma under CareSource include the Asthma Medication Ratio (AMR), which evaluates the proportion of controller to reliever medications, and Use of Appropriate Medications for People with Asthma (ASM). Achieving high performance on these measures often correlates with efficient prior authorization processes for guideline-adherent treatments.
Does CareSource offer specific disease management programs for asthma patients?
Yes, CareSource, as a non-profit health plan, typically provides robust disease management programs. These programs for asthma patients often include educational resources, care coordination services, and support for medication adherence, all aimed at improving health outcomes and reducing acute exacerbations.
How can we reduce PA-related delays for high-volume asthma treatments with CareSource?
Implementing an automated prior authorization platform like Klivira can significantly reduce delays. By integrating with your EMR, Klivira automates the submission of clinical documentation, tracks PA status, and alerts staff to necessary follow-ups, streamlining the entire CareSource asthma prior authorization workflow.
What impact does CareSource's focus on Medicaid/ACA have on asthma PA?
CareSource's focus on Medicaid and ACA populations means a higher prevalence of chronic conditions like asthma, often with complex social determinants of health. This can lead to a greater volume of PA requests and a stronger emphasis on cost-effective, evidence-based treatments and adherence to HEDIS quality measures.
Related coverage
Ready to automate prior auth for this condition?
See how Klivira automates prior authorizations for your team.
Request a demo